ArticleAntioxidants (Basel, Switzerland)Published
CRISPR/Cas9-Based Screening of FDA-Approved Drugs for NRF2 Activation: A Novel Approach to Discover Therapeutics for Non-Alcoholic Fatty Liver Disease
Regional connection
Verified An author affiliation on the Europe PMC record names Temple University. Affiliation source
- Institution
- Temple University
- County
- Philadelphia County
Publication record
- Type
- Article
- Venue
- Antioxidants (Basel, Switzerland)
- Published
- Topic
- Disease research
- Subject terms
- Oxidative stress; NRF2; Nafld; Fatty Liver Disease; Crispr/cas9; Hmox1
- PubMed ID
- 37507903
- PubMed Central ID
- PMC10375998
- Open access
- Yes, open
- Added to directory
- Source checked